当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 资产负债表

科伦药业

(002422)

  

流通市值:466.33亿  总市值:570.66亿
流通股本:13.06亿   总股本:15.98亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金5,127,588,8076,108,344,6216,288,440,8474,675,476,376
应收票据及应收账款4,732,202,0404,716,304,9524,969,551,9844,682,762,166
应收账款4,732,202,0404,716,304,9524,969,551,9844,682,762,166
应收款项融资1,671,154,0341,799,908,4011,873,566,4571,437,398,168
预付款项664,303,605416,402,286515,559,923386,355,181
其他应收款合计185,399,051181,793,494189,479,846162,491,989
其中:应收利息4,682,2154,602,9374,523,6594,444,381
应收股利9,973,76615,205,328--
存货3,293,343,2023,249,419,9283,536,918,1953,839,798,313
其他流动资产1,435,595,5931,434,768,9461,292,519,5941,414,658,711
流动资产平衡项目0000
流动资产合计19,065,882,89718,930,129,68119,208,487,06718,290,026,502
非流动资产:
长期股权投资4,139,727,7594,062,902,4774,040,051,4333,976,374,504
其他权益工具投资40,768,71340,768,71340,768,71315,768,713
固定资产10,636,441,6299,972,625,59610,046,126,6559,750,132,489
在建工程1,715,774,5472,285,554,1621,926,839,4332,044,627,639
使用权资产645,829,315623,962,644295,309,733290,740,511
无形资产1,220,142,8791,237,373,4051,260,239,9731,277,104,872
开发支出8,923,44613,267,03513,105,43219,772,786
商誉98,659,99498,659,99498,659,99498,659,994
长期待摊费用81,525,17585,579,99787,495,43955,950,498
递延所得税资产390,635,478370,505,922354,634,569342,570,903
其他非流动资产348,052,143319,739,924304,739,924293,171,729
非流动资产平衡项目0000
非流动资产合计19,326,481,07819,110,939,86918,467,971,29818,164,874,638
资产平衡项目0000
资产总计38,392,363,97538,041,069,55037,676,458,36536,454,901,140
流动负债:
短期借款2,592,048,7053,184,206,1833,262,372,6553,458,268,168
交易性金融负债-256,100551,43331,500
应付票据及应付账款2,437,190,5292,607,770,3432,568,722,2962,538,869,444
其中:应付票据216,511,903347,862,771510,703,859374,753,277
应付账款2,220,678,6262,259,907,5722,058,018,4372,164,116,167
合同负债237,144,252169,941,735569,095,751715,239,002
应付职工薪酬444,551,052225,093,766200,714,713308,078,424
应交税费284,073,147254,027,307440,022,584276,942,797
其他应付款合计2,472,366,0652,156,193,1512,092,632,9281,884,641,099
应付股利413,663,16235,4001,400,8251,416,225
一年内到期的非流动负债748,863,083417,375,824532,547,414787,389,381
其他流动负债926,483,897618,588,25025,576,82623,650,378
流动负债平衡项目0000
流动负债合计10,142,720,7309,633,452,6599,692,236,6009,993,110,193
非流动负债:
长期借款888,950,0001,364,950,0001,294,960,0001,082,293,333
应付债券--1,710,2541,566,294,362
租赁负债558,839,740537,316,013256,769,132245,226,090
预计负债5,468,5623,215,6501,411,10177,901
递延收益292,042,504301,989,332290,061,855288,206,388
递延所得税负债272,899,667268,670,568266,857,095264,099,307
其他非流动负债---0
非流动负债平衡项目0000
非流动负债合计2,018,200,4732,476,141,5632,111,769,4373,446,197,381
负债平衡项目0000
负债合计12,160,921,20312,109,594,22211,804,006,03713,439,307,574
所有者权益(或股东权益):
实收资本(或股本)1,601,592,1731,601,592,1731,601,592,1731,499,102,945
其他权益工具---170,218,080
资本公积8,301,331,6138,275,829,9107,773,192,0866,143,659,862
减:库存股192,981,304192,981,304213,606,257215,141,160
其他综合收益84,901,857118,971,28797,376,26598,823,253
专项储备2,761,9712,885,0342,969,5153,024,515
盈余公积1,419,788,3081,419,788,3081,419,788,3081,419,788,308
未分配利润11,337,635,11311,080,446,84111,579,090,36210,552,902,186
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计22,555,029,73122,306,532,24922,260,402,45219,672,377,989
少数股东权益3,676,413,0413,624,943,0793,612,049,8763,343,215,577
股东权益平衡项目0000
股东权益合计26,231,442,77225,931,475,32825,872,452,32823,015,593,566
负债和股东权益合计38,392,363,97538,041,069,55037,676,458,36536,454,901,140
公告日期2024-10-292024-08-292024-04-252024-04-25
审计意见(境内)标准无保留意见
TOP↑